Hartford Investment Management CO Abbott Laboratories Transaction History

Hartford Investment Management CO

$2.8 Billion
Q1 2024

A detailed history of Hartford Investment Management CO transactions in Abbott Laboratories stock. As of the latest transaction made, Hartford Investment Management CO holds 112,197 shares of ABT stock, worth $11.7 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

112,197

Previous 116,879 4.01%

Holding current value

$11.7 Million

Previous $12.9 Million 0.87%

% of portfolio

0.46%

Previous 0.48%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	SELL	$109.52 - $120.96 $512,772 - $566,334	-4,682 Reduced 4.01%	112,197 $12.8 Million
Q4 2023 Jan 23, 2024	SELL	$90.19 - $110.4 $188,857 - $231,177	-2,094 Reduced 1.76%	116,879 $12.9 Million
Q3 2023 Oct 16, 2023	SELL	$95.53 - $114.62 $353,078 - $423,635	-3,696 Reduced 3.01%	118,973 $11.5 Million
Q2 2023 Jul 19, 2023	SELL	$100.78 - $112.29 $2.5 Million - $2.79 Million	-24,808 Reduced 16.82%	122,669 $13.4 Million
Q1 2023 May 09, 2023	BUY	$96.86 - $114.01 $2 Million - $2.35 Million	20,651 Added 16.28%	147,477 $14.9 Million

Q4 2022 Jan 20, 2023	SELL	$95.06 - $111.52 $4.85 Million - $5.68 Million	-50,975 Reduced 28.67%	126,826 $13.9 Million
Q3 2022 Nov 02, 2022	BUY	$96.76 - $112.03 $94,728 - $109,677	979 Added 0.55%	177,801 $17.2 Million
Q2 2022 Jul 22, 2022	BUY	$102.07 - $123.37 $68,284 - $82,534	669 Added 0.38%	176,822 $19.2 Million
Q1 2022 Apr 20, 2022	SELL	$114.02 - $139.04 $1.42 Million - $1.73 Million	-12,449 Reduced 6.6%	176,153 $20.8 Million
Q4 2021 Feb 02, 2022	BUY	$115.53 - $141.46 $1.61 Million - $1.97 Million	13,902 Added 7.96%	188,602 $26.5 Million
Q3 2021 Nov 01, 2021	SELL	$116.66 - $129.06 $2.51 Million - $2.78 Million	-21,507 Reduced 10.96%	174,700 $20.6 Million
Q2 2021 Jul 29, 2021	SELL	$105.79 - $124.53 $408,772 - $481,183	-3,864 Reduced 1.93%	196,207 $22.7 Million
Q1 2021 Apr 21, 2021	SELL	$108.84 - $128.23 $743,594 - $876,067	-6,832 Reduced 3.3%	200,071 $24 Million
Q4 2020 Feb 01, 2021	BUY	$105.0 - $114.42 $2.1 Million - $2.29 Million	20,012 Added 10.71%	206,903 $22.7 Million
Q3 2020 Oct 29, 2020	SELL	$91.64 - $111.29 $634,240 - $770,238	-6,921 Reduced 3.57%	186,891 $20.3 Million
Q2 2020 Aug 04, 2020	SELL	$76.57 - $98.0 $2.25 Million - $2.88 Million	-29,383 Reduced 13.16%	193,812 $17.7 Million
Q1 2020 Apr 24, 2020	BUY	$62.82 - $91.86 $74,001 - $108,211	1,178 Added 0.53%	223,195 $17.6 Million
Q4 2019 Jan 29, 2020	SELL	$78.51 - $87.4 $265,520 - $295,586	-3,382 Reduced 1.5%	222,017 $19.3 Million
Q3 2019 Oct 28, 2019	SELL	$81.84 - $88.74 $1.55 Million - $1.68 Million	-18,942 Reduced 7.75%	225,399 $18.9 Million
Q2 2019 Jul 25, 2019	BUY	$72.88 - $85.0 $186,499 - $217,515	2,559 Added 1.06%	244,341 $20.5 Million
Q1 2019 Apr 29, 2019	BUY	$66.22 - $80.06 $567,306 - $685,874	8,567 Added 3.67%	241,782 $19.3 Million
Q4 2018 Feb 04, 2019	BUY	$65.56 - $74.27 $151,705 - $171,860	2,314 Added 1.0%	233,215 $16.9 Million
Q3 2018 Nov 08, 2018	SELL	$60.81 - $73.36 $660,883 - $797,276	-10,868 Reduced 4.5%	230,901 $16.9 Million
Q2 2018 Jul 19, 2018	SELL	$57.57 - $63.54 $6.67 Million - $7.36 Million	-115,871 Reduced 32.4%	241,769 $14.7 Million
Q1 2018 Apr 24, 2018	SELL	$56.27 - $63.62 $1.71 Million - $1.93 Million	-30,404 Reduced 7.84%	357,640 $21.4 Million
Q4 2017 Feb 12, 2018	SELL	$53.68 - $57.47 $764,510 - $818,487	-14,242 Reduced 3.54%	388,044 $22.1 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $19.3 Million - $21.6 Million	402,286	402,286 $21.5 Million

Others Institutions Holding ABT

# of Institutions

3,127

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $182B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartford Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Hartford Investment Management CO with notifications on news.

Account

Hartford Investment Management CO Abbott Laboratories Transaction History